0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pandemic Influenza Vaccine Market Insights Forecast to 2025
Published Date: April 2019
|
Report Code: QYRE-Othe-0141
Home | Category |Health |Health Conditions |Infectious Diseases
Global Pandemic Influenza Vaccine Market Insights Forecast to 2025

Global Pandemic Influenza Vaccine Market Insights Forecast to 2025

Code: QYRE-Othe-0141
Report
April 2019
111 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures

Influenza vaccines treat influenza by developing antibodies in the body within two weeks after vaccination. These antibodies protect against infections with the help of the attenuated viruses in the vaccine. These vaccines contain killed or inactivated strains of the influenza virus.

The global Pandemic Influenza Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pandemic Influenza Vaccine market based on company, product type, end user and key regions.

 

This report studies the global market size of Pandemic Influenza Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pandemic Influenza Vaccine in these regions.

This research report categorizes the global Pandemic Influenza Vaccine market by top players/brands, region, type and end user. This report also studies the global Pandemic Influenza Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

 

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

AstraZeneca

GlaxoSmithKline

Novartis

Sanofi

Valneva

Lupin

Chiron Panacea

Solvay and Serum Institute of India Pvt. Ltd.

Sementis

 

Market size by Product

Influenza A (H1N1) Vaccines

Other

Market size by End User

Adult

Paediatric

 

Market size by Region

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Europe

Germany

France

UK

Italy

Spain

Russia

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa

 

The study objectives of this report are:

To study and analyze the global Pandemic Influenza Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

To understand the structure of Pandemic Influenza Vaccine market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Pandemic Influenza Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

To project the value and sales volume of Pandemic Influenza Vaccine submarkets, with respect to key regions.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

 

In this study, the years considered to estimate the market size of Pandemic Influenza Vaccine are as follows:

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2019 to 2025

 

This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pandemic Influenza Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

 

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

 

Table of Contents

 

1 Study Coverage

1.1 Pandemic Influenza Vaccine Product

1.2 Market Segments

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Product

1.4.2 Influenza A (H1N1) Vaccines

1.4.3 Other

1.5 Market by End User

1.5.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by End User

1.5.2 Adult

1.5.3 Paediatric

1.6 Study Objectives

1.7 Years Considered

 

2 Executive Summary

2.1 Global Pandemic Influenza Vaccine Market Size

2.1.1 Global Pandemic Influenza Vaccine Revenue 2014-2025

2.1.2 Global Pandemic Influenza Vaccine Sales 2014-2025

2.2 Pandemic Influenza Vaccine Growth Rate by Regions

2.2.1 Global Pandemic Influenza Vaccine Sales by Regions

2.2.2 Global Pandemic Influenza Vaccine Revenue by Regions

 

3 Breakdown Data by Manufacturers

3.1 Pandemic Influenza Vaccine Sales by Manufacturers

3.1.1 Pandemic Influenza Vaccine Sales by Manufacturers

3.1.2 Pandemic Influenza Vaccine Sales Market Share by Manufacturers

3.1.3 Global Pandemic Influenza Vaccine Market Concentration Ratio (CR5 and HHI)

3.2 Pandemic Influenza Vaccine Revenue by Manufacturers

3.2.1 Pandemic Influenza Vaccine Revenue by Manufacturers (2014-2019)

3.2.2 Pandemic Influenza Vaccine Revenue Share by Manufacturers (2014-2019)

3.3 Pandemic Influenza Vaccine Price by Manufacturers

3.4 Pandemic Influenza Vaccine Manufacturing Base Distribution, Product Types

3.4.1 Pandemic Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Pandemic Influenza Vaccine Product Type

3.4.3 Date of International Manufacturers Enter into Pandemic Influenza Vaccine Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

 

4 Breakdown Data by Product

4.1 Global Pandemic Influenza Vaccine Sales by Product

4.2 Global Pandemic Influenza Vaccine Revenue by Product

4.3 Pandemic Influenza Vaccine Price by Product

 

5 Breakdown Data by End User

5.1 Overview

5.2 Global Pandemic Influenza Vaccine Breakdown Data by End User

 

6 North America

6.1 North America Pandemic Influenza Vaccine by Countries

6.1.1 North America Pandemic Influenza Vaccine Sales by Countries

6.1.2 North America Pandemic Influenza Vaccine Revenue by Countries

6.1.3 United States

6.1.4 Canada

6.1.5 Mexico

6.2 North America Pandemic Influenza Vaccine by Product

6.3 North America Pandemic Influenza Vaccine by End User

 

7 Europe

7.1 Europe Pandemic Influenza Vaccine by Countries

7.1.1 Europe Pandemic Influenza Vaccine Sales by Countries

7.1.2 Europe Pandemic Influenza Vaccine Revenue by Countries

7.1.3 Germany

7.1.4 France

7.1.5 UK

7.1.6 Italy

7.1.7 Russia

7.2 Europe Pandemic Influenza Vaccine by Product

7.3 Europe Pandemic Influenza Vaccine by End User

 

8 Asia Pacific

8.1 Asia Pacific Pandemic Influenza Vaccine by Countries

8.1.1 Asia Pacific Pandemic Influenza Vaccine Sales by Countries

8.1.2 Asia Pacific Pandemic Influenza Vaccine Revenue by Countries

8.1.3 China

8.1.4 Japan

8.1.5 Korea

8.1.6 India

8.1.7 Australia

8.1.8 Indonesia

8.1.9 Malaysia

8.1.10 Philippines

8.1.11 Thailand

8.1.12 Vietnam

8.1.13 Singapore

8.2 Asia Pacific Pandemic Influenza Vaccine by Product

8.3 Asia Pacific Pandemic Influenza Vaccine by End User

 

9 Central & South America

9.1 Central & South America Pandemic Influenza Vaccine by Countries

9.1.1 Central & South America Pandemic Influenza Vaccine Sales by Countries

9.1.2 Central & South America Pandemic Influenza Vaccine Revenue by Countries

9.1.3 Brazil

9.2 Central & South America Pandemic Influenza Vaccine by Product

9.3 Central & South America Pandemic Influenza Vaccine by End User

 

10 Middle East and Africa

10.1 Middle East and Africa Pandemic Influenza Vaccine by Countries

10.1.1 Middle East and Africa Pandemic Influenza Vaccine Sales by Countries

10.1.2 Middle East and Africa Pandemic Influenza Vaccine Revenue by Countries

10.1.3 GCC Countries

10.1.4 Turkey

10.1.5 Egypt

10.1.6 South Africa

10.2 Middle East and Africa Pandemic Influenza Vaccine by Product

10.3 Middle East and Africa Pandemic Influenza Vaccine by End User

 

11 Company Profiles

11.1 AstraZeneca

11.1.1 AstraZeneca Company Details

11.1.2 Company Business Overview

11.1.3 AstraZeneca Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.1.4 AstraZeneca Pandemic Influenza Vaccine Products Offered

11.1.5 AstraZeneca Recent Development

11.2 GlaxoSmithKline

11.2.1 GlaxoSmithKline Company Details

11.2.2 Company Business Overview

11.2.3 GlaxoSmithKline Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.2.4 GlaxoSmithKline Pandemic Influenza Vaccine Products Offered

11.2.5 GlaxoSmithKline Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Company Business Overview

11.3.3 Novartis Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.3.4 Novartis Pandemic Influenza Vaccine Products Offered

11.3.5 Novartis Recent Development

11.4 Sanofi

11.4.1 Sanofi Company Details

11.4.2 Company Business Overview

11.4.3 Sanofi Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.4.4 Sanofi Pandemic Influenza Vaccine Products Offered

11.4.5 Sanofi Recent Development

11.5 Valneva

11.5.1 Valneva Company Details

11.5.2 Company Business Overview

11.5.3 Valneva Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.5.4 Valneva Pandemic Influenza Vaccine Products Offered

11.5.5 Valneva Recent Development

11.6 Lupin

11.6.1 Lupin Company Details

11.6.2 Company Business Overview

11.6.3 Lupin Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.6.4 Lupin Pandemic Influenza Vaccine Products Offered

11.6.5 Lupin Recent Development

11.7 Chiron Panacea

11.7.1 Chiron Panacea Company Details

11.7.2 Company Business Overview

11.7.3 Chiron Panacea Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.7.4 Chiron Panacea Pandemic Influenza Vaccine Products Offered

11.7.5 Chiron Panacea Recent Development

11.8 Solvay and Serum Institute of India Pvt. Ltd.

11.8.1 Solvay and Serum Institute of India Pvt. Ltd. Company Details

11.8.2 Company Business Overview

11.8.3 Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.8.4 Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Products Offered

11.8.5 Solvay and Serum Institute of India Pvt. Ltd. Recent Development

11.9 Sementis

11.9.1 Sementis Company Details

11.9.2 Company Business Overview

11.9.3 Sementis Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.9.4 Sementis Pandemic Influenza Vaccine Products Offered

11.9.5 Sementis Recent Development

 

12 Future Forecast

12.1 Pandemic Influenza Vaccine Market Forecast by Regions

12.1.1 Global Pandemic Influenza Vaccine Sales Forecast by Regions 2019-2025

12.1.2 Global Pandemic Influenza Vaccine Revenue Forecast by Regions 2019-2025

12.2 Pandemic Influenza Vaccine Market Forecast by Product

12.2.1 Global Pandemic Influenza Vaccine Sales Forecast by Product 2019-2025

12.2.2 Glo

List of Tables and Figures

 

Figure Pandemic Influenza Vaccine Product Picture

Table Pandemic Influenza Vaccine Market Segments

Table Key Manufacturers Pandemic Influenza Vaccine Covered

Table Global Pandemic Influenza Vaccine Market Size Growth Rate by Product 2019-2025 (K Doses) & (Million US$)

Figure Global Pandemic Influenza Vaccine Sales Market Share by Product 2014-2025

Figure Influenza A (H1N1) Vaccines Product Picture

Table Major Manufacturers of Influenza A (H1N1) Vaccines

Figure Other Product Picture

Table Major Manufacturers of Other

Table Global Pandemic Influenza Vaccine Market Size Growth Rate by End User 2019-2025 (K Doses)

Figure Adult

Figure Paediatric

Figure Pandemic Influenza Vaccine Report Years Considered

Figure Global Pandemic Influenza Vaccine Market Size 2014-2025 (Million US$)

Figure Global Pandemic Influenza Vaccine Sales 2014-2025 (K Doses)

Table Global Pandemic Influenza Vaccine Market Size by Regions 2014-2019 (K Doses) & (Million US$)

Table Global Pandemic Influenza Vaccine Sales by Regions 2014-2019 (K Doses)

Table Global Pandemic Influenza Vaccine Sales Market Share by Regions 2014-2019

Figure Global Pandemic Influenza Vaccine Sales Market Share by Regions 2014-2019

Figure 2018 Global Pandemic Influenza Vaccine Sales Market Share by Regions

Table Global Pandemic Influenza Vaccine Revenue by Regions 2014-2019 (Million US$)

Table Global Pandemic Influenza Vaccine Revenue Market Share by Regions 2014-2019

Figure Global Pandemic Influenza Vaccine Revenue Market Share by Regions 2014-2019

Figure 2018 Global Pandemic Influenza Vaccine Revenue Market Share by Regions

Table Global Pandemic Influenza Vaccine Sales by Manufacturers (2014-2019) (K Doses)

Table Global Pandemic Influenza Vaccine Sales Share by Manufacturers (2014-2019)

Figure Global Pandemic Influenza Vaccine Sales Share by Manufacturers in 2018

Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table Pandemic Influenza Vaccine Revenue by Manufacturers (2014-2019) (Million USD)

Table Pandemic Influenza Vaccine Revenue Share by Manufacturers (2014-2019)

Figure Pandemic Influenza Vaccine Value Share by Manufacturers in 2018

Table Key Manufacturers Pandemic Influenza Vaccine Price (2014-2019) (USD/Dose)

Table Pandemic Influenza Vaccine Manufacturers Manufacturing Base Distribution and Headquarters

Table Manufacturers Pandemic Influenza Vaccine Product Type

Table Date of International Manufacturers Enter into Pandemic Influenza Vaccine Market

Table Manufacturers Mergers & Acquisitions, Expansion Plans

Table Global Pandemic Influenza Vaccine Sales by Product (2014-2019) (K Doses)

Table Global Pandemic Influenza Vaccine Sales Share by Product (2014-2019)

Figure Global Pandemic Influenza Vaccine Sales Market Share by Product (2014-2019)

Figure Global Pandemic Influenza Vaccine Sales Market Share by Product in 2018

Table Global Pandemic Influenza Vaccine Revenue by Product (2014-2019) (Million US$)

Table Global Pandemic Influenza Vaccine Revenue Share by Product (2014-2019)

Figure Global Pandemic Influenza Vaccine Revenue Market Share by Product (2014-2019)

Figure Global Pandemic Influenza Vaccine Revenue Market Share by Product in 2018

Table Pandemic Influenza Vaccine Price by Product 2014-2019 (USD/Dose)

Table Global Pandemic Influenza Vaccine Sales by End User (2014-2019) (K Doses)

Table Global Pandemic Influenza Vaccine Sales Share by End User (2014-2019)

Figure Global Sales Pandemic Influenza Vaccine Market Share by End User (2014-2019)

Figure Global Sales Pandemic Influenza Vaccine Market Share by End User in 2018

Figure North America Pandemic Influenza Vaccine Sales Growth Rate 2014-2019 (K Doses)

Figure North America Pandemic Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)

Table North America Pandemic Influenza Vaccine Sales by Countries (2014-2019) (K Doses)

Table North America Pandemic Influenza Vaccine Sales Market Share by Countries (2014-2019)

Figure 2018 North America Pandemic Influenza Vaccine Sales Market Share by Countries

Table North America Pandemic Influenza Vaccine Revenue by Countries (2014-2019) (Million US$)

Table North America Pandemic Influenza Vaccine Revenue Market Share by Countries (2014-2019)

Figure 2018 North America Pandemic Influenza Vaccine Revenue Market Share by Countries

Figure United States Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure United States Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (K Doses)

Figure Canada Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Canada Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure Mexico Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Mexico Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Table North America Pandemic Influenza Vaccine Sales by Product (2014-2019) (K Doses)

Table North America Pandemic Influenza Vaccine Sales Market Share by Product (2014-2019)

Figure 2018 North America Pandemic Influenza Vaccine Market Share by Product

Table North America Pandemic Influenza Vaccine Sales by End User (2014-2019) (K Doses)

Table North America Pandemic Influenza Vaccine Sales Market Share by End User (2014-2019)

Figure 2018 North America Pandemic Influenza Vaccine Market Share by End User

Figure Europe Pandemic Influenza Vaccine Sales Growth Rate 2014-2019 (K Doses)

Figure Europe Pandemic Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)

Table Europe Pandemic Influenza Vaccine Sales by Countries (2014-2019) (K Doses)

Table Europe Pandemic Influenza Vaccine Sales Market Share by Countries (2014-2019)

Figure 2018 Europe Pandemic Influenza Vaccine Sales Market Share by Countries

Table Europe Pandemic Influenza Vaccine Revenue by Countries (2014-2019) (Million US$)

Table Europe Pandemic Influenza Vaccine Revenue Market Share by Countries (2014-2019)

Figure 2018 Europe Pandemic Influenza Vaccine Revenue Market Share by Countries

Figure Germany Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Germany Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure France Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure France Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure UK Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure UK Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure Italy Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Italy Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure Russia Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Russia Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Table Europe Pandemic Influenza Vaccine Sales by Product (2014-2019) (K Doses)

Table Europe Pandemic Influenza Vaccine Sales Market Share by Product (2014-2019)

Figure 2018 Europe Pandemic Influenza Vaccine Market Share by Product

Table Europe Pandemic Influenza Vaccine Sales by End User (2014-2019) (K Doses)

Table Europe Pandemic Influenza Vaccine Sales Market Share by End User (2014-2019)

Figure 2018 Europe Pandemic Influenza Vaccine Market Share by End User

Figure Asia Pacific Pandemic Influenza Vaccine Sales Growth Rate 2014-2019 (K Doses)

Figure Asia Pacific Pandemic Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)

Table Asia Pacific Pandemic Influenza Vaccine Sales by Countries (2014-2019) (K Doses)

Table Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Countries (2014-2019)

Figure 2018 Asia Pacific Pandemic Influenza Vaccine Sales Market Share by C

Influenza vaccines treat influenza by developing antibodies in the body within two weeks after vaccination. These antibodies protect against infections with the help of the attenuated viruses in the vaccine. These vaccines contain killed or inactivated strains of the influenza virus.

The global Pandemic Influenza Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pandemic Influenza Vaccine market based on company, product type, end user and key regions.

 

This report studies the global market size of Pandemic Influenza Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pandemic Influenza Vaccine in these regions.

This research report categorizes the global Pandemic Influenza Vaccine market by top players/brands, region, type and end user. This report also studies the global Pandemic Influenza Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

 

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

AstraZeneca

GlaxoSmithKline

Novartis

Sanofi

Valneva

Lupin

Chiron Panacea

Solvay and Serum Institute of India Pvt. Ltd.

Sementis

 

Market size by Product

Influenza A (H1N1) Vaccines

Other

Market size by End User

Adult

Paediatric

 

Market size by Region

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Europe

Germany

France

UK

Italy

Spain

Russia

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa

 

The study objectives of this report are:

To study and analyze the global Pandemic Influenza Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

To understand the structure of Pandemic Influenza Vaccine market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Pandemic Influenza Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

To project the value and sales volume of Pandemic Influenza Vaccine submarkets, with respect to key regions.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

 

In this study, the years considered to estimate the market size of Pandemic Influenza Vaccine are as follows:

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2019 to 2025

 

This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pandemic Influenza Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

 

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

 

Read More

Table of Contents

 

1 Study Coverage

1.1 Pandemic Influenza Vaccine Product

1.2 Market Segments

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Product

1.4.2 Influenza A (H1N1) Vaccines

1.4.3 Other

1.5 Market by End User

1.5.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by End User

1.5.2 Adult

1.5.3 Paediatric

1.6 Study Objectives

1.7 Years Considered

 

2 Executive Summary

2.1 Global Pandemic Influenza Vaccine Market Size

2.1.1 Global Pandemic Influenza Vaccine Revenue 2014-2025

2.1.2 Global Pandemic Influenza Vaccine Sales 2014-2025

2.2 Pandemic Influenza Vaccine Growth Rate by Regions

2.2.1 Global Pandemic Influenza Vaccine Sales by Regions

2.2.2 Global Pandemic Influenza Vaccine Revenue by Regions

 

3 Breakdown Data by Manufacturers

3.1 Pandemic Influenza Vaccine Sales by Manufacturers

3.1.1 Pandemic Influenza Vaccine Sales by Manufacturers

3.1.2 Pandemic Influenza Vaccine Sales Market Share by Manufacturers

3.1.3 Global Pandemic Influenza Vaccine Market Concentration Ratio (CR5 and HHI)

3.2 Pandemic Influenza Vaccine Revenue by Manufacturers

3.2.1 Pandemic Influenza Vaccine Revenue by Manufacturers (2014-2019)

3.2.2 Pandemic Influenza Vaccine Revenue Share by Manufacturers (2014-2019)

3.3 Pandemic Influenza Vaccine Price by Manufacturers

3.4 Pandemic Influenza Vaccine Manufacturing Base Distribution, Product Types

3.4.1 Pandemic Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Pandemic Influenza Vaccine Product Type

3.4.3 Date of International Manufacturers Enter into Pandemic Influenza Vaccine Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

 

4 Breakdown Data by Product

4.1 Global Pandemic Influenza Vaccine Sales by Product

4.2 Global Pandemic Influenza Vaccine Revenue by Product

4.3 Pandemic Influenza Vaccine Price by Product

 

5 Breakdown Data by End User

5.1 Overview

5.2 Global Pandemic Influenza Vaccine Breakdown Data by End User

 

6 North America

6.1 North America Pandemic Influenza Vaccine by Countries

6.1.1 North America Pandemic Influenza Vaccine Sales by Countries

6.1.2 North America Pandemic Influenza Vaccine Revenue by Countries

6.1.3 United States

6.1.4 Canada

6.1.5 Mexico

6.2 North America Pandemic Influenza Vaccine by Product

6.3 North America Pandemic Influenza Vaccine by End User

 

7 Europe

7.1 Europe Pandemic Influenza Vaccine by Countries

7.1.1 Europe Pandemic Influenza Vaccine Sales by Countries

7.1.2 Europe Pandemic Influenza Vaccine Revenue by Countries

7.1.3 Germany

7.1.4 France

7.1.5 UK

7.1.6 Italy

7.1.7 Russia

7.2 Europe Pandemic Influenza Vaccine by Product

7.3 Europe Pandemic Influenza Vaccine by End User

 

8 Asia Pacific

8.1 Asia Pacific Pandemic Influenza Vaccine by Countries

8.1.1 Asia Pacific Pandemic Influenza Vaccine Sales by Countries

8.1.2 Asia Pacific Pandemic Influenza Vaccine Revenue by Countries

8.1.3 China

8.1.4 Japan

8.1.5 Korea

8.1.6 India

8.1.7 Australia

8.1.8 Indonesia

8.1.9 Malaysia

8.1.10 Philippines

8.1.11 Thailand

8.1.12 Vietnam

8.1.13 Singapore

8.2 Asia Pacific Pandemic Influenza Vaccine by Product

8.3 Asia Pacific Pandemic Influenza Vaccine by End User

 

9 Central & South America

9.1 Central & South America Pandemic Influenza Vaccine by Countries

9.1.1 Central & South America Pandemic Influenza Vaccine Sales by Countries

9.1.2 Central & South America Pandemic Influenza Vaccine Revenue by Countries

9.1.3 Brazil

9.2 Central & South America Pandemic Influenza Vaccine by Product

9.3 Central & South America Pandemic Influenza Vaccine by End User

 

10 Middle East and Africa

10.1 Middle East and Africa Pandemic Influenza Vaccine by Countries

10.1.1 Middle East and Africa Pandemic Influenza Vaccine Sales by Countries

10.1.2 Middle East and Africa Pandemic Influenza Vaccine Revenue by Countries

10.1.3 GCC Countries

10.1.4 Turkey

10.1.5 Egypt

10.1.6 South Africa

10.2 Middle East and Africa Pandemic Influenza Vaccine by Product

10.3 Middle East and Africa Pandemic Influenza Vaccine by End User

 

11 Company Profiles

11.1 AstraZeneca

11.1.1 AstraZeneca Company Details

11.1.2 Company Business Overview

11.1.3 AstraZeneca Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.1.4 AstraZeneca Pandemic Influenza Vaccine Products Offered

11.1.5 AstraZeneca Recent Development

11.2 GlaxoSmithKline

11.2.1 GlaxoSmithKline Company Details

11.2.2 Company Business Overview

11.2.3 GlaxoSmithKline Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.2.4 GlaxoSmithKline Pandemic Influenza Vaccine Products Offered

11.2.5 GlaxoSmithKline Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Company Business Overview

11.3.3 Novartis Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.3.4 Novartis Pandemic Influenza Vaccine Products Offered

11.3.5 Novartis Recent Development

11.4 Sanofi

11.4.1 Sanofi Company Details

11.4.2 Company Business Overview

11.4.3 Sanofi Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.4.4 Sanofi Pandemic Influenza Vaccine Products Offered

11.4.5 Sanofi Recent Development

11.5 Valneva

11.5.1 Valneva Company Details

11.5.2 Company Business Overview

11.5.3 Valneva Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.5.4 Valneva Pandemic Influenza Vaccine Products Offered

11.5.5 Valneva Recent Development

11.6 Lupin

11.6.1 Lupin Company Details

11.6.2 Company Business Overview

11.6.3 Lupin Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.6.4 Lupin Pandemic Influenza Vaccine Products Offered

11.6.5 Lupin Recent Development

11.7 Chiron Panacea

11.7.1 Chiron Panacea Company Details

11.7.2 Company Business Overview

11.7.3 Chiron Panacea Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.7.4 Chiron Panacea Pandemic Influenza Vaccine Products Offered

11.7.5 Chiron Panacea Recent Development

11.8 Solvay and Serum Institute of India Pvt. Ltd.

11.8.1 Solvay and Serum Institute of India Pvt. Ltd. Company Details

11.8.2 Company Business Overview

11.8.3 Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.8.4 Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Products Offered

11.8.5 Solvay and Serum Institute of India Pvt. Ltd. Recent Development

11.9 Sementis

11.9.1 Sementis Company Details

11.9.2 Company Business Overview

11.9.3 Sementis Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)

11.9.4 Sementis Pandemic Influenza Vaccine Products Offered

11.9.5 Sementis Recent Development

 

12 Future Forecast

12.1 Pandemic Influenza Vaccine Market Forecast by Regions

12.1.1 Global Pandemic Influenza Vaccine Sales Forecast by Regions 2019-2025

12.1.2 Global Pandemic Influenza Vaccine Revenue Forecast by Regions 2019-2025

12.2 Pandemic Influenza Vaccine Market Forecast by Product

12.2.1 Global Pandemic Influenza Vaccine Sales Forecast by Product 2019-2025

12.2.2 Glo

Read More

List of Tables and Figures

 

Figure Pandemic Influenza Vaccine Product Picture

Table Pandemic Influenza Vaccine Market Segments

Table Key Manufacturers Pandemic Influenza Vaccine Covered

Table Global Pandemic Influenza Vaccine Market Size Growth Rate by Product 2019-2025 (K Doses) & (Million US$)

Figure Global Pandemic Influenza Vaccine Sales Market Share by Product 2014-2025

Figure Influenza A (H1N1) Vaccines Product Picture

Table Major Manufacturers of Influenza A (H1N1) Vaccines

Figure Other Product Picture

Table Major Manufacturers of Other

Table Global Pandemic Influenza Vaccine Market Size Growth Rate by End User 2019-2025 (K Doses)

Figure Adult

Figure Paediatric

Figure Pandemic Influenza Vaccine Report Years Considered

Figure Global Pandemic Influenza Vaccine Market Size 2014-2025 (Million US$)

Figure Global Pandemic Influenza Vaccine Sales 2014-2025 (K Doses)

Table Global Pandemic Influenza Vaccine Market Size by Regions 2014-2019 (K Doses) & (Million US$)

Table Global Pandemic Influenza Vaccine Sales by Regions 2014-2019 (K Doses)

Table Global Pandemic Influenza Vaccine Sales Market Share by Regions 2014-2019

Figure Global Pandemic Influenza Vaccine Sales Market Share by Regions 2014-2019

Figure 2018 Global Pandemic Influenza Vaccine Sales Market Share by Regions

Table Global Pandemic Influenza Vaccine Revenue by Regions 2014-2019 (Million US$)

Table Global Pandemic Influenza Vaccine Revenue Market Share by Regions 2014-2019

Figure Global Pandemic Influenza Vaccine Revenue Market Share by Regions 2014-2019

Figure 2018 Global Pandemic Influenza Vaccine Revenue Market Share by Regions

Table Global Pandemic Influenza Vaccine Sales by Manufacturers (2014-2019) (K Doses)

Table Global Pandemic Influenza Vaccine Sales Share by Manufacturers (2014-2019)

Figure Global Pandemic Influenza Vaccine Sales Share by Manufacturers in 2018

Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table Pandemic Influenza Vaccine Revenue by Manufacturers (2014-2019) (Million USD)

Table Pandemic Influenza Vaccine Revenue Share by Manufacturers (2014-2019)

Figure Pandemic Influenza Vaccine Value Share by Manufacturers in 2018

Table Key Manufacturers Pandemic Influenza Vaccine Price (2014-2019) (USD/Dose)

Table Pandemic Influenza Vaccine Manufacturers Manufacturing Base Distribution and Headquarters

Table Manufacturers Pandemic Influenza Vaccine Product Type

Table Date of International Manufacturers Enter into Pandemic Influenza Vaccine Market

Table Manufacturers Mergers & Acquisitions, Expansion Plans

Table Global Pandemic Influenza Vaccine Sales by Product (2014-2019) (K Doses)

Table Global Pandemic Influenza Vaccine Sales Share by Product (2014-2019)

Figure Global Pandemic Influenza Vaccine Sales Market Share by Product (2014-2019)

Figure Global Pandemic Influenza Vaccine Sales Market Share by Product in 2018

Table Global Pandemic Influenza Vaccine Revenue by Product (2014-2019) (Million US$)

Table Global Pandemic Influenza Vaccine Revenue Share by Product (2014-2019)

Figure Global Pandemic Influenza Vaccine Revenue Market Share by Product (2014-2019)

Figure Global Pandemic Influenza Vaccine Revenue Market Share by Product in 2018

Table Pandemic Influenza Vaccine Price by Product 2014-2019 (USD/Dose)

Table Global Pandemic Influenza Vaccine Sales by End User (2014-2019) (K Doses)

Table Global Pandemic Influenza Vaccine Sales Share by End User (2014-2019)

Figure Global Sales Pandemic Influenza Vaccine Market Share by End User (2014-2019)

Figure Global Sales Pandemic Influenza Vaccine Market Share by End User in 2018

Figure North America Pandemic Influenza Vaccine Sales Growth Rate 2014-2019 (K Doses)

Figure North America Pandemic Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)

Table North America Pandemic Influenza Vaccine Sales by Countries (2014-2019) (K Doses)

Table North America Pandemic Influenza Vaccine Sales Market Share by Countries (2014-2019)

Figure 2018 North America Pandemic Influenza Vaccine Sales Market Share by Countries

Table North America Pandemic Influenza Vaccine Revenue by Countries (2014-2019) (Million US$)

Table North America Pandemic Influenza Vaccine Revenue Market Share by Countries (2014-2019)

Figure 2018 North America Pandemic Influenza Vaccine Revenue Market Share by Countries

Figure United States Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure United States Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (K Doses)

Figure Canada Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Canada Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure Mexico Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Mexico Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Table North America Pandemic Influenza Vaccine Sales by Product (2014-2019) (K Doses)

Table North America Pandemic Influenza Vaccine Sales Market Share by Product (2014-2019)

Figure 2018 North America Pandemic Influenza Vaccine Market Share by Product

Table North America Pandemic Influenza Vaccine Sales by End User (2014-2019) (K Doses)

Table North America Pandemic Influenza Vaccine Sales Market Share by End User (2014-2019)

Figure 2018 North America Pandemic Influenza Vaccine Market Share by End User

Figure Europe Pandemic Influenza Vaccine Sales Growth Rate 2014-2019 (K Doses)

Figure Europe Pandemic Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)

Table Europe Pandemic Influenza Vaccine Sales by Countries (2014-2019) (K Doses)

Table Europe Pandemic Influenza Vaccine Sales Market Share by Countries (2014-2019)

Figure 2018 Europe Pandemic Influenza Vaccine Sales Market Share by Countries

Table Europe Pandemic Influenza Vaccine Revenue by Countries (2014-2019) (Million US$)

Table Europe Pandemic Influenza Vaccine Revenue Market Share by Countries (2014-2019)

Figure 2018 Europe Pandemic Influenza Vaccine Revenue Market Share by Countries

Figure Germany Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Germany Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure France Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure France Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure UK Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure UK Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure Italy Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Italy Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Figure Russia Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)

Figure Russia Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)

Table Europe Pandemic Influenza Vaccine Sales by Product (2014-2019) (K Doses)

Table Europe Pandemic Influenza Vaccine Sales Market Share by Product (2014-2019)

Figure 2018 Europe Pandemic Influenza Vaccine Market Share by Product

Table Europe Pandemic Influenza Vaccine Sales by End User (2014-2019) (K Doses)

Table Europe Pandemic Influenza Vaccine Sales Market Share by End User (2014-2019)

Figure 2018 Europe Pandemic Influenza Vaccine Market Share by End User

Figure Asia Pacific Pandemic Influenza Vaccine Sales Growth Rate 2014-2019 (K Doses)

Figure Asia Pacific Pandemic Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)

Table Asia Pacific Pandemic Influenza Vaccine Sales by Countries (2014-2019) (K Doses)

Table Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Countries (2014-2019)

Figure 2018 Asia Pacific Pandemic Influenza Vaccine Sales Market Share by C

Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Multi User

Electronic (PDF)
$5850
This license allows multiple user to access the PDF.

Enterprise License

Electronic (PDF)
$7800
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Leap India

RELATED REPORTS

Global Meningococcal Vaccine Market Research Report 2021
Global Meningococcal Vaccine Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-31I4138
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Latent tuberculosis Testing Market Size Status and Forecast 2021 2027
Global Latent tuberculosis Testing Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-33Z4080
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Avian Influenza Vaccines Market Research Report 2021
Global Avian Influenza Vaccines Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-9K4476
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Polio Vaccine Market Research Report 2021
Global Polio Vaccine Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-18B4237
Mon Feb 01 00:00:00 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0